Key result
T2DM is linked to ~13% higher aortic stiffness but no difference in augmentation index.
Why the study?
Patients with type 2 diabetes mellitus have increased arterial stiffness but not increased augmentation index, suggesting different mechanisms contributing to AIx in T2DM compared with healthy individuals.
Does Augmentation index (AIx) correlate with systemic arterial stiffness in patients with type 2 diabetes mellitus compared to controls?
Population
53 patients with type 2 diabetes mellitus and 53 matched controls
Comparison
Patients with type 2 diabetes mellitus vs matched controls
Design
Case-control study
Authors
Loading...
AIx should not be used as a stiffness marker in T2DM; leaves open distinct determinants needing prospective validation.
Case-Control (n=106)
No
Does Augmentation index (AIx) correlate with systemic arterial stiffness in patients with type 2 diabetes mellitus compared to controls?
Absolute Event Rate: 27% vs 24%
p-value: p=0.184
Augmentation index is not significantly related to regional large artery stiffness in T2DM patients or controls and should not be used as a surrogate marker for systemic arterial stiffness.
Climie et al. (2013) conducted a case-control in Type 2 diabetes mellitus (n=106). Type 2 diabetes mellitus vs. Healthy controls was evaluated on Central augmentation index (%) (p=0.184). Patients with type 2 diabetes mellitus had significantly higher aortic stiffness (7.6 vs 6.7 m/s) compared to healthy controls, but no significant difference in augmentation index (27% vs 24%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: